deepak agarkar's profile

Autologous Cell Therapy Market

deepak agarkar
•
Autologous Cell Therapy Market Forecast 2019 - 2027​​​​​​​

According to Transparency Market Research’s latest report on the global autologous cell therapy market for the historical period 2017–2018 and forecast period 2019–2027, Rise in prevalence of autoimmune disorders, cancer, blood related disorders, are projected to drive the global autologous cell therapy market during the forecast period
According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in 2018 and is anticipated to expand at a CAGR of 18.1% from 2019 to 2027


Rise in Prevalence of Autoimmune Disorders, Cancer, Neurodegenerative Disease Increase the Demand of Autologous cell therapy: Key Drivers
The global autologous cell therapy market continues to expand at a high growth rate due to increasing prevalence of autoimmune diseases, cancer orthopedic disorders. According to AARDA (American Autoimmune Related Diseases Association), around 50 Mn people in U.S. suffering from autoimmune diseases and this number is expected to rise in the future. In addition increasing use of autologous cell therapy in the treatment of several conditions such as neurological, orthopedic, oncology, and a wide range of autoimmune diseases. Is likely to drive the growth of this market during forecasted period.
According to American Cancer Society, 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States in 2019.
According to The Parkinson's Foundation, Currently more than 10 million people worldwide are living with Parkinson's disease (PD).
Strong Product Pipeline and Increasing Government Support Boost Market Growth
Major manufacturers are focusing on research and development activity for new autologous cell therapy products. Currently TESSA Therapeutics has innovative autologous cell therapy product (TT12) in pipeline i.e. Phase 1 for treatment of HPV-Associated Cancers. Strong product pipeline is helps to drive the growth of this market.
Increasing government support and funding is likely to drive the growth of this market during forecasted period. National Institute of Health (NIH) had spent around US$ 2 Bn for stem cells research in the U.S. in 2019.
Government regulations against unethical harvesting of stem cells and lack of reimbursement in emerging countries to hamper market
Reproductive cloning is banned in U.S. European nations such as Germany, Austria, Portugal and Italy and some Asian nations such as China, South Korea and Israel. However, therapeutic cloning is permitted. The restrictions on research activities had hampered the growth of stem cells and thereby restricting the demand for autologous cell therapy products.
Reimbursements are provided by various governments and private insurance agencies to meet the needs of several patient undergo cell therapy (autologous) treatment. However, lack of reimbursement policies in various less developed and emerging economies for treatment with the help of cell therapy and high cost of treatment restrain the market


Global Autologous cell therapy Market: Competitive Landscape
This report profiles major players in the global autologous cell therapy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The global autologous cell therapy market is highly fragmented, with the presence of a number of international as well as regional players
Leading players operating in the global autologous cell therapy market are
Pharmicell Co., Inc.
Castle Creek Biosciences, Inc.
Vericel Corporation
Lineage Cell Therapeutics, Inc.
BrainStorm Cell Therapeutics
Caladrius Biosciences, Inc.
Opexa Therapeutics, Inc.
Regeneus Ltd.
Takeda Pharmaceutical Company Limited.
Sangamo Therapeutics
U.S. Stem Cell, Inc.



About Transparency Market Research

Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research company providing custom research and consulting services. TMR provides in-depth insights into factors governing demand in the market. It divulges opportunities across various segments based on Source, Application, Sales Channel, and End-Use that will favor growth in the market over the next 9 years.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com




Autologous Cell Therapy Market
Published:
deepak agarkar's profile

Owner

deepak agarkar's profile
India

Autologous Cell Therapy Market

Published:

Creative Fields